MPS Powered by Eureka

Current Cardiology Reviews

ISSN: 1573-403X (Print)
eISSN: 1875-6557 (Online)

Current Cardiology Reviews publishes full-length reviews/mini-reviews and guest edited thematic issues of high quality on all the latest advances on cardiovascular physiology and physiopathology, and on the practical and clinical approach to the diagnosis and treatment of cardiovascular disease, cardiac disease prevention, surgery, and transplantation. All relevant areas are covered by the journal, including arrhythmia, congestive heart failure, cardiomyopathy, congenital heart disease, drugs, methodology, cardiac testing, pacing, medical devices, and preventive cardiology. The journal is essential reading for all researchers and clinicians in cardiology.

Special Issues With Active Call for Papers

Submission closes on: Apr 16, 2025
Advances in Managing Cardiogenic Shock and the Value of Percutaneous Mechanical Circulatory Support.

Despite the advances in cardiology, the outcomes of patients with cardiogenic shock remain poor. There is an increasing interest and use of mechanical circulatory support for patients with cardiogenic shock. Additionally, the complexity of coronary interventions has increased during the last decade with the potential of treating more high-risk patients who benefit from mechanical circulatory support during the intervention. The scope of this thematic issue is to highlight (1) the pathophysiology of cardiogenic shock and... see more

Submission closes on: Dec 10, 2024
The era of cardiac medication and implantable devices therapy in heart failure treatment continues

The heart failure (HF) remains a serious public health problem and affects 64 million people worldwide. Although advances in medical therapy and device assistance have significantly improved HF outcomes, the implications of HF are still dramatic. In recent years, innovative developments have been made in HF treatment management, based on robust evidence from drug treatment trials. Furthermore, cardiac resynchronization therapy (CRT) is the therapy with the most proven effectiveness in HF patients with a reduced... see more